Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.
Pierre S, Chevallier A, Teixeira-Clerc F, Ambolet-Camoit A, Bui LC, Bats AS, Fournet JC, Fernandez-Salguero P, Aggerbeck M, Lotersztajn S, Barouki R, Coumoul X. Pierre S, et al. Among authors: lotersztajn s. Toxicol Sci. 2014 Jan;137(1):114-24. doi: 10.1093/toxsci/kft236. Epub 2013 Oct 23. Toxicol Sci. 2014. PMID: 24154488
Hepatic fibrosis: molecular mechanisms and drug targets.
Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Lotersztajn S, et al. Annu Rev Pharmacol Toxicol. 2005;45:605-28. doi: 10.1146/annurev.pharmtox.45.120403.095906. Annu Rev Pharmacol Toxicol. 2005. PMID: 15471534 Review.
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S. Julien B, et al. Among authors: lotersztajn s. Gastroenterology. 2005 Mar;128(3):742-55. doi: 10.1053/j.gastro.2004.12.050. Gastroenterology. 2005. PMID: 15765409
[CB1 cannabinoid receptor antagonists: a novel approach for the treatment of liver fibrosis].
Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. Teixeira-Clerc F, et al. Among authors: lotersztajn s. Med Sci (Paris). 2006 Aug-Sep;22(8-9):683-5. doi: 10.1051/medsci/20062289683. Med Sci (Paris). 2006. PMID: 16962033 Free article. French. No abstract available.
The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing.
Serriere-Lanneau V, Teixeira-Clerc F, Li L, Schippers M, de Wries W, Julien B, Tran-Van-Nhieu J, Manin S, Poelstra K, Chun J, Carpentier S, Levade T, Mallat A, Lotersztajn S. Serriere-Lanneau V, et al. Among authors: lotersztajn s. FASEB J. 2007 Jul;21(9):2005-13. doi: 10.1096/fj.06-6889com. Epub 2007 Mar 6. FASEB J. 2007. PMID: 17341687
[Endocannabinoids: therapeutic perspectives in chronic liver diseases].
Lotersztajn S, Teixeira-Clerc F, Hezode C, Tran van Nhieu J, Deveaux V, Mallat A. Lotersztajn S, et al. Gastroenterol Clin Biol. 2007 Mar;31(3):255-8. doi: 10.1016/s0399-8320(07)89369-9. Gastroenterol Clin Biol. 2007. PMID: 17396081 Free article. French. No abstract available.
[The endocannabinoid system as a novel target for the treatment of liver fibrosis].
Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Hezode C, Mallat A, Lotersztajn S. Teixeira-Clerc F, et al. Among authors: lotersztajn s. Pathol Biol (Paris). 2008 Feb;56(1):36-8. doi: 10.1016/j.patbio.2007.01.001. Epub 2007 Apr 6. Pathol Biol (Paris). 2008. PMID: 17412522 Review. French.
136 results